{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:20:04Z","timestamp":1763662804289},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.trsl.2009.09.009","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T04:47:11Z","timestamp":1255582031000},"page":"123-130","source":"Crossref","is-referenced-by-count":23,"title":["Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial"],"prefix":"10.1016","volume":"155","author":[{"given":"Fred","family":"Askari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawna","family":"Innis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Greenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2009.09.009_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.60.3.379","article-title":"Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy","volume":"60","author":"Brewer","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.trsl.2009.09.009_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneur.63.4.521","article-title":"Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease","volume":"63","author":"Brewer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.trsl.2009.09.009_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1568009053765807","article-title":"Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer","volume":"5","author":"Brewer","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.trsl.2009.09.009_bib4","first-page":"1","article-title":"Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study","volume":"6","author":"Brewer","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2009.09.009_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.athoracsur.2008.03.016","article-title":"A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results","volume":"86","author":"Pass","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.trsl.2009.09.009_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1067\/mlc.2003.20","article-title":"Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice","volume":"141","author":"Brewer","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2009.09.009_bib7","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jinorgbio.2004.10.006","article-title":"Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis","volume":"98","author":"Brewer","year":"2004","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.trsl.2009.09.009_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/153537020422900820","article-title":"Tetrathiomolybdate therapy protects against concanavalin A and carbon tetrachloride hepatic damage in mice","volume":"229","author":"Askari","year":"2004","journal-title":"Exp Bio Med"},{"key":"10.1016\/j.trsl.2009.09.009_bib9","first-page":"419","article-title":"Tetrathiomolybdate protects against liver injury from acetaminophen in mice","volume":"4","author":"Ma","year":"2004","journal-title":"J Appl Res Clin Exp Ther"},{"key":"10.1016\/j.trsl.2009.09.009_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.107.131227","article-title":"Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis","volume":"325","author":"Song","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2009.09.009_bib11","unstructured":"Flaherty KR, Arenberg DA, White ES, et\u00a0al. Treatment of idiopathic pulmonary fibrosis with tetrathiomolybdate. In press."},{"key":"10.1016\/j.trsl.2009.09.009_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.lab.2005.07.004","article-title":"Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice","volume":"146","author":"Hou","year":"2005","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2009.09.009_bib13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jinorgbio.2005.10.007","article-title":"The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model","volume":"100","author":"Brewer","year":"2006","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.trsl.2009.09.009_bib14","first-page":"2501","article-title":"Tetrathiomolybdate is effective in a mouse model of arthritis","volume":"33","author":"McCubbin","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2009.09.009_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.trsl.2008.09.003","article-title":"Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis","volume":"152","author":"Hou","year":"2008","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2009.09.009_bib16","series-title":"Harrison's principles of internal medicine","first-page":"1757","article-title":"Cirrhosis and its complications: primary biliary cirrhosis","author":"Chung","year":"2001"},{"key":"10.1016\/j.trsl.2009.09.009_bib17","unstructured":"Digestive Disease Interagency Coordinating Committee. Translational research in primary biliary cirrhosis. Available at: http:\/\/www2.niddk.nih.gov\/NR\/rdonlyres\/8FC7A357-1BA5-4068-9B6D-AA012EA3FD3D\/0\/DDICC_June_16_2003_Minutes.pdf. Accessed November 19, 2007."},{"key":"10.1016\/j.trsl.2009.09.009_bib18","unstructured":"Pyrsopoulos NT, Reddy KR, Wu GY, et\u00a0al. Primary biliary cirrhosis. Available at: http:\/\/www.emedicine.com\/MED\/topic223.htm. Accessed December 11, 2008."},{"key":"10.1016\/j.trsl.2009.09.009_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0090-1229(86)90049-8","article-title":"In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis","volume":"41","author":"Colucci","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.trsl.2009.09.009_bib20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2009.09.009_bib21","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMct074694","article-title":"Ursodeoxycholic acid for the treatment of primary biliary cirrhosis","volume":"357","author":"Lindor","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2009.09.009_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10637-008-9165-9","article-title":"A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer","volume":"27","author":"Gartner","year":"2009","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.trsl.2009.09.009_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000106066","article-title":"Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone refractory prostate cancer","volume":"71","author":"Henry","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.trsl.2009.09.009_bib24","first-page":"1666","article-title":"Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer","volume":"9","author":"Redman","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2009.09.009_bib25","first-page":"73","article-title":"Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration","volume":"100","author":"Vine","year":"2002","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524409002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524409002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:18:33Z","timestamp":1558574313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524409002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1931524409002965"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2009.09.009","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}